Publication | Closed Access

The use of new quinazolinone derivative and doxorubicin loaded solid lipid nanoparticles in reversing drug resistance in experimental cancer cell lines: A systematic study

NanomedicineHealth SciencesPolymer-drug ConjugateMedicineSolid Lipid NanoparticlesNew QuinazolinonePharmaceutical NanotechnologyTumor TargetingPharmacologyRadiation OncologyDrug DiscoveryDrug Resistance